INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 146 filers reported holding INTELLIA THERAPEUTICS INC in Q2 2019. The put-call ratio across all filers is 0.71 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $19,372,822 | +83.5% | 865,631 | +125.5% | 0.01% | +100.0% |
| Q1 2024 | $10,560,209 | -27.2% | 383,868 | -19.3% | 0.00% | -40.0% |
| Q4 2023 | $14,505,557 | -9.8% | 475,748 | -6.5% | 0.01% | -16.7% |
| Q3 2023 | $16,080,667 | -21.3% | 508,560 | +1.5% | 0.01% | -14.3% |
| Q2 2023 | $20,440,078 | +51725.8% | 501,228 | -52.6% | 0.01% | -53.3% |
| Q1 2023 | $39,440 | +70.2% | 1,058,218 | +59.3% | 0.02% | +66.7% |
| Q4 2022 | $23,174 | -99.9% | 664,206 | +69.8% | 0.01% | 0.0% |
| Q3 2022 | $21,893,000 | -0.2% | 391,224 | -7.7% | 0.01% | +12.5% |
| Q2 2022 | $21,942,000 | -7.6% | 423,914 | +24.9% | 0.01% | 0.0% |
| Q1 2022 | $23,752,000 | -43.3% | 339,494 | -4.2% | 0.01% | -33.3% |
| Q4 2021 | $41,916,000 | -19.0% | 354,508 | -8.1% | 0.01% | -25.0% |
| Q3 2021 | $51,752,000 | -27.8% | 385,780 | -12.9% | 0.02% | -23.8% |
| Q2 2021 | $71,686,000 | +61.2% | 442,757 | -20.1% | 0.02% | +50.0% |
| Q1 2021 | $44,459,000 | +60.5% | 553,957 | +8.8% | 0.01% | +55.6% |
| Q4 2020 | $27,703,000 | +203.5% | 509,235 | +10.9% | 0.01% | +125.0% |
| Q3 2020 | $9,129,000 | -1.6% | 459,200 | +4.1% | 0.00% | 0.0% |
| Q2 2020 | $9,276,000 | +155.6% | 441,283 | +48.7% | 0.00% | +100.0% |
| Q1 2020 | $3,629,000 | -58.7% | 296,715 | -50.5% | 0.00% | -33.3% |
| Q4 2019 | $8,794,000 | +344.1% | 599,403 | +304.2% | 0.00% | +200.0% |
| Q3 2019 | $1,980,000 | -18.0% | 148,301 | +0.5% | 0.00% | 0.0% |
| Q2 2019 | $2,416,000 | – | 147,585 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HIMENSION CAPITAL (SINGAPORE) PTE. LTD. | 744,160 | $54,078,000 | 5.79% |
| Discovery Value Fund | 986,173 | $71,665,000 | 5.28% |
| Ally Bridge Group (NY) LLC | 60,000 | $4,360,000 | 3.23% |
| MPM BioImpact LLC | 159,409 | $11,584,000 | 3.11% |
| ARK Investment Management | 8,981,029 | $652,651,000 | 2.72% |
| Elmwood Wealth Management, Inc. | 67,599 | $4,912,000 | 2.52% |
| Nikko Asset Management Americas, Inc. | 2,872,269 | $192,442,000 | 1.41% |
| Frazier Life Sciences Management, L.P. | 203,684 | $14,802,000 | 1.26% |
| REGENTS OF THE UNIVERSITY OF CALIFORNIA | 111,440 | $8,098,000 | 1.22% |
| Merlin Capital, Inc | 11,575 | $841,000 | 1.11% |